Xuelin (Steve) Wang
Lawyers
Filters
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
Laekna HK$587 million placement of shares
We advised Laekna on the placement of new shares
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Ascletis HK$861.98 million placement of shares and top-up subscription
We advised the placing agent on the placement and the top-up subscription
Adagene $25 million strategic equity investment from Sanofi
We advised Adagene on the transaction
Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing
Mirxes Holding Company HK$1.09 billion IPO
We advised Mirxes on its IPO and HKEX listing
PegBio IPO
We advised PegBio on its IPO and HKEX listing